FDA Inspection
Acrotech Biopharma Inc.Acrotech Biopharma Inc. – FDA Inspection, Nov 18, 2024
Record Details
This FDA Inspection record concerns Acrotech Biopharma Inc., with an inspection on November 18, 2024, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · f0ec4968-f49d-4d2a-a936-12f0a2711b4b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254819
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
3- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 314.80(d)Failure to submit scientific article
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Acrotech Biopharma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Acrotech Biopharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.